![](/img/cover-not-exists.png)
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study
Kuo, Ching-Yuan, Wang, Po-Nan, Hwang, Wen-Li, Tzeng, Cheng-Hwai, Bai, Li-Yaun, Tang, Jih-Luh, Chang, Ming-Chih, Lin, Sheng-Fung, Chen, Tsai-Yun, Chen, Yeu-Chin, Tan, Tran-Der, Hsieh, Chih-Yi, Lin, ChiVolume:
9
Language:
english
Journal:
Therapeutic Advances in Hematology
DOI:
10.1177/2040620718756603
Date:
March, 2018
File:
PDF, 259 KB
english, 2018